Safety and Efficacy of Aliskiren + Hydrochlorothiazide (± Amlodipine 5 mg) in Patients With Moderate Hypertension

NCT00867490 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

186

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: Candesartan+HCTZ - Phase 1
DRUG: Aliskiren+HCTZ - Phase 2
DRUG: Aliskiren+HCTZ+amlodipine - Phase 3

Sponsor

Novartis